What is the Brexit Health Alliance?
Bringing together the NHS, medical research, industry, patients and public health organisations, the Brexit Health Alliance aims to safeguard the interests of patients and the healthcare and research they rely on during the Brexit negotiations.
It is co-chaired by Sir Hugh Taylor, the former permanent secretary of the Department of Health and Chair of Guy’s and St Thomas’ NHS Foundation Trust, and Niall Dickson, the Chief Executive of the NHS Confederation.
The Alliance is working to ensure that issues such as healthcare research, access to technologies and treatment of patients are given the prominence and attention they deserve in the Brexit negotiations, and argues that it is in both Europe and the UK’s interests to maintain co-operation in research and in handling public health issues. It has also called on the UK government to make sure there is a commitment to medical research and providing alternative funding, and that UK citizens’ right to receive healthcare in EU countries is preserved.
Full details of the Alliance's negotiation priorities can be found in the collective 'asks' document. There is also a one-page summary for quick reference. This infographic also provides an at-a-glance summary of the Brexit Health Alliance's key areas of focus.
The Alliance is complementary and works in a synergic way with the Cavendish Coalition, which brings bring together group of 37 health and social care organisations and focuses on addressing the potential impacts of Brexit on the health and social care workforce. The Cavendish Coalition acts as a shared voice to influence and lobby on post-Brexit issues, ensuring the UK has a continued domestic and international pipeline of high calibre professionals and trainees in health and social care.
More information is available in the Cavendish Coalition web pages.
What are the Alliance's key areas of focus?
The Alliance does not take any stance on the merits or otherwise of Brexit. Its aim is to make sure that we are in the strongest possible position once the UK leaves the EU, and to this effect it advocates a negotiated implementation period that adequately reflects the time needed to achieve the following desired outcomes:
- Supporting maximum levels of research and innovation collaboration, ensuring that patients are able to benefit from international research collaborations post-Brexit
- Ensuring regulatory alignment for the benefit of patients and the public’s health, so that UK patients continue to benefit from early access to the wide range of innovative health technologies available
- Preserving reciprocal healthcare arrangements
- Ensuring robust coordination mechanisms on public health and wellbeing
- Securing a strong funding commitment to the health sector and the public’s health, promoting solutions to minimise any potential additional pressures which may result from Brexit, as well as advocating for any loss of EU funds for the sector to be offset by alternative funding.
We will run campaigns in each of these areas to highlight the Alliance's concerns and ensure they are given the prominence and attention they deserve as the UK negotiates its exit from the EU.
The first of our campaigns focused on preserving reciprocal healthcare arrangements and took place during the week of 16 October. You can access all the campaign information on our dedicated reciprocal healthcare page.
Who are the Alliance’s founding members?
- Academy of Medical Royal Colleges
- Association of Medical Research Charities
- Association of British Health Tech Industries
- Association of the British Pharmaceutical Industry
- Association of UK University Hospitals
- BioIndustry Association
- Faculty of Public Health
- Medical Schools Council
- National Voices
- NHS Confederation (including Mental Health Network, NHS Clinical Commissioners, NHS Employers, NHS Partners Network)
- NHS Providers
- Northern Ireland Confederation for Health and Social Care
- Richmond Group of Charities
- Scottish NHS Chief Executive Group
- Welsh NHS Confederation.